Pieter van Doorn

Prof. Pieter van Doorn is a Full Professor in Neurology at Erasmus MC, part of Erasmus University Rotterdam. His research focuses on neuromuscular disorders, immunology, and clinical trials, particularly in enzyme replacement therapies for metabolic storage disorders (e.g., Pompe disease) and immune-mediated neuropathies such as CIDP. He has contributed to advancements in biomarkers like neurofilament light chain for Guillain-Barré syndrome prognosis and cost-effective diagnostic protocols for polyneuropathies.

Key areas of interest include the application of adoptive cell therapy in autoimmune diseases and statistical methodologies in neurologic trials. His work bridges clinical practice and translational research, with over 435 research outputs. Notable collaborations span Europe and involve interdisciplinary teams addressing neuroimmunology and metabolic disorders.

Prof. van Doorn has presented on topics such as IVIG treatment for CIDP and vasculitis-related neuropathies since the late 1990s. His contributions were highlighted in media (e.g., 2005 coverage on muscle pain/cramps) and include protocol development (EXPRESS Study) to optimize patient care efficiency.